Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-26-000098
Filing Date
2026-01-28
Accepted
2026-01-28 12:46:06
Documents
1
Effectiveness Date
2026-01-28

Document Format Files

Seq Description Document Type Size
1 PLYX_8A_Cert_2075320.pdf CERT 81500
  Complete submission text file 0001354457-26-000098.txt   113451
Mailing Address SOUTH TOWER, 140 E RIDGEWOOD AVENUE SUITE 415 PARAMUS NJ 07652
Business Address 140 EAST RIDGEWOOD AVENUE SUITE 415, SOUTH TOWER PARAMUS NJ 07652 201-940-7236
Polaryx Therapeutics, Inc. (Filer) CIK: 0002075320 (see all company filings)

EIN.: 000000000 | State of Incorp.: WY | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-43080 | Film No.: 26570683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)